Infliximab associated new-onset psoriasis

J Drugs Dermatol. 2006 Feb;5(2):178-9.

Abstract

Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Dermatologic Agents / adverse effects*
  • Humans
  • Inflammatory Bowel Diseases / drug therapy
  • Infliximab
  • Male
  • Psoriasis / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Infliximab